DK1974721T3 - Injiceringsdygtig steril farmaceutisk sammensætning med natriumpiperacillin og natriumtazobactam som aktive stoffer - Google Patents
Injiceringsdygtig steril farmaceutisk sammensætning med natriumpiperacillin og natriumtazobactam som aktive stofferInfo
- Publication number
- DK1974721T3 DK1974721T3 DK07122822.5T DK07122822T DK1974721T3 DK 1974721 T3 DK1974721 T3 DK 1974721T3 DK 07122822 T DK07122822 T DK 07122822T DK 1974721 T3 DK1974721 T3 DK 1974721T3
- Authority
- DK
- Denmark
- Prior art keywords
- sodium
- pharmaceutical composition
- sterile pharmaceutical
- tazobactam
- piperacillin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 title 1
- 229910052708 sodium Inorganic materials 0.000 title 1
- 239000011734 sodium Substances 0.000 title 1
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 title 1
- 229960003865 tazobactam Drugs 0.000 title 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- TUPFOYXHAYOHIB-YCAIQWGJSA-M sodium;(2s,5r,6r)-6-[[(2r)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(2s,3s,5r)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]h Chemical compound [Na+].C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1.O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 TUPFOYXHAYOHIB-YCAIQWGJSA-M 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000568A ITMI20070568A1 (it) | 2007-03-22 | 2007-03-22 | Comosizione farmaceutica sterile iniettabile avente piperacillina sodica e tazobactam sodico come principi attivi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1974721T3 true DK1974721T3 (da) | 2011-10-24 |
Family
ID=39673190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07122822.5T DK1974721T3 (da) | 2007-03-22 | 2007-12-11 | Injiceringsdygtig steril farmaceutisk sammensætning med natriumpiperacillin og natriumtazobactam som aktive stoffer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8765190B2 (da) |
| EP (1) | EP1974721B1 (da) |
| AT (1) | ATE516018T1 (da) |
| DK (1) | DK1974721T3 (da) |
| ES (1) | ES2369441T3 (da) |
| IT (1) | ITMI20070568A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| MX2020004205A (es) | 2013-03-15 | 2021-11-16 | Merck Sharp & Dohme Llc | Composiciones antibioticas de ceftolozano. |
| US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
| EP3043797B1 (en) | 2013-09-09 | 2020-04-08 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| CN115554298A (zh) * | 2021-07-01 | 2023-01-03 | 北京诺康达医药科技股份有限公司 | 一种他唑巴坦和哌拉西林的联合制剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2925963A1 (de) * | 1979-06-27 | 1981-01-22 | Bayer Ag | Penicillin-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel |
| WO2004098643A1 (en) | 2003-04-14 | 2004-11-18 | Wyeth Holdings Corporation | Compositions containing piperacillin and tazobactam useful for injection |
| JP2007519747A (ja) | 2004-01-30 | 2007-07-19 | ワイス | ピペラシリンおよびタゾバクタムを含みガラクトマンナンを実質的には含まない組成物 |
| JP2008516967A (ja) | 2004-10-14 | 2008-05-22 | ワイス | 乳酸ナトリウム希釈液中にピペラシリン、タゾバクタムおよびアミノカルボン酸を含む組成物 |
| ITMI20051630A1 (it) | 2005-09-02 | 2007-03-03 | Acs Dobfar Spa | Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi |
-
2007
- 2007-03-22 IT IT000568A patent/ITMI20070568A1/it unknown
- 2007-12-06 US US11/951,589 patent/US8765190B2/en active Active
- 2007-12-11 ES ES07122822T patent/ES2369441T3/es active Active
- 2007-12-11 AT AT07122822T patent/ATE516018T1/de active
- 2007-12-11 DK DK07122822.5T patent/DK1974721T3/da active
- 2007-12-11 EP EP07122822A patent/EP1974721B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| ES2369441T3 (es) | 2011-11-30 |
| ATE516018T1 (de) | 2011-07-15 |
| EP1974721A1 (en) | 2008-10-01 |
| ITMI20070568A1 (it) | 2008-09-23 |
| EP1974721B1 (en) | 2011-07-13 |
| US8765190B2 (en) | 2014-07-01 |
| US20080233196A1 (en) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1974721T3 (da) | Injiceringsdygtig steril farmaceutisk sammensætning med natriumpiperacillin og natriumtazobactam som aktive stoffer | |
| ATE499090T1 (de) | Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan | |
| ATE486593T1 (de) | Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack | |
| CL2012003197A1 (es) | Formulación farmacéutica acuosa que comprende 200-1000 u/ml de insulina glargina, con condición de que la concentración de dicha formulación no sea 684 u/ml de insulina glargina; y su uso para tratar diabetes mellitus de tipo i y tipo ii en un paciente. | |
| AR060836A1 (es) | Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido | |
| AR058133A1 (es) | Metodo de tratamiento y/o prevencion de infecciones en bebes nacidos por cesarea | |
| TW200728285A (en) | Diacylindazole derivatives as inhibitors of lipases and phospholipases | |
| PE20080658A1 (es) | Formulaciones de metilnaltrexona en forma de polvo seco | |
| CL2011000170A1 (es) | Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa. | |
| CL2011000891A1 (es) | Uso de la cepa probiotica lactobacillus reuteri dsm17938 o una composicion nutricional que comprende una cepa bacteriana probiotica lactobacillus reuteri dsm17938 porque sirve para preparar un medicamento o una composicion nutricional util para reducir las alteraciones de sueño y/o mejorar la calidad del sueño o los patrones de sueño en humanos o animales. | |
| EA200601654A1 (ru) | Ингибиторы интегразы вич | |
| NO20064584L (no) | Tetrahydropyridoindolderivater | |
| AR049063A1 (es) | Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas | |
| ECSP109852A (es) | Uso de homo y copolímeros para la estabilización de formulaciones de principios activos | |
| NO20075111L (no) | Farmasoytisk sammensetning | |
| BRPI0709847B8 (pt) | composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio | |
| DE602006001699D1 (de) | Stabile pharmazeutische Zusammensetzung mit Linezolid Form IV | |
| AR077138A1 (es) | Composiciones farmaceuticas utiles para tratar el vhc | |
| EA201290833A1 (ru) | Применение амисульприда в качестве противорвотного средства | |
| NZ599265A (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| CL2009000919A1 (es) | Uso de dronedarona o una sal farmaceuticamente aceptable para preparar un medicamento util en la prevencion y/o tratamiento de la hipocalemia. | |
| DE60219963D1 (de) | Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes | |
| CL2012003119A1 (es) | Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre. | |
| AR044831A1 (es) | Forma de administracion inyectable de la flupirtina | |
| BR112015008964A2 (pt) | composições injetáveis estáveis contendo diclofenaco e tiocolquicosídeo |